Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by reprogramming macrophages and increasing UCP1 expression in vascular smooth muscle cells
A. Stachowicz, A. Wisniewska, K. Czepiel, B. Pomierny, A. Skorkowska, B. Kusnierz-Cabala, M. Surmiak, K. Kus, M. E. Wood, R. Torregrossa, M. Whiteman, R. Olszanecki
This study shows that the mitochondrial H2S donor AP39 reduces atherosclerosis by reprogramming macrophages and increasing UCP1 in vascular smooth muscle cells.
bioRxiv · May 15, 2024 · PreprintPharmacology & Toxicology